Stock Screener App

Frei -

Installieren

7.90

2.95% -0.24

after-market

Handel nachbörslich: 7.78 -0.12 -1.52%

Contineum Therapeutics Inc (CTNM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Contineum Therapeutics Inc-Aktie (CTNM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	3.10% 17.43	16.90	17.11	14.93	17.90
Operating Income/Loss	3.10% -17.43	-16.90	-17.11	-14.93	-17.90
Nonoperating Income/Loss	7.11% 2.274	2.448	1.959	2.41	1.862
Net Income/Loss	4.83% -15.15	-14.46	-15.16	-12.79	-16.04
Basic Average Shares	0.34% 37.47	37.34	1.0658	28.12	25.90
Diluted Average Shares	0.34% 37.47	37.34	-	-	-
Basic Earnings Per Share	2.56% -0.40	-0.39	-0.49	-0.45	-0.62
Diluted Earnings Per Share	2.56% -0.40	-0.39	-	-	-

PHAT

$7.50

1.35%

ZVRA

$10.27

0.39%

SLDB

$5.74

5.03%

NVCT

$18.93

5.17%

CLYM

$10.91

6.03%

WVE

$3.19

3.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters